Zivo Bioscience transitions to OTCID marketplace
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace
May 12, 2026 10:09 AM EDTTROY, Mich.--(BUSINESS WIRE)-- Zivo Bioscience, Inc. (OTCID: ZIVO) ("ZIVO" or the "Company") announced today that it is transitioning its common stock to quotation on the OTCID marketplace.
Zivo Bioscience began trading on OTCID as of Monday, May 11, 2026.
Transitioning to OTCID is a common step for companies seeking to maintain public trading while aligning with a marketplace that offers streamlined reporting requirements, improved flexibility, and continued visibility for investors. Companies moving to OTCID typically do so to promote continued trading, maintain shareholder access to liquidity, and... More
